MicroRNA Regulation for Inflammasomes in High Glucose-Treated ARPE-19 Cells

Purpose. This study aimed to evaluate the expression of microRNAs (miRNAs) and inflammasomes in diabetes-induced retinal cells and to determine their role in the pathogenesis of diabetic retinopathy (DR). Methods. To establish diabetes-induced cell models, ARPE-19 cells were treated with high glucos...

Full description

Saved in:
Bibliographic Details
Main Authors: Ji Hong Kim, Hyoseon Yu, Ji Hye Kang, Eun Hee Hong, Min Ho Kang, Mincheol Seong, Heeyoon Cho, Yong Un Shin
Format: Article
Language:English
Published: Wiley 2024-01-01
Series:Journal of Ophthalmology
Online Access:http://dx.doi.org/10.1155/2024/3654690
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841561389709131776
author Ji Hong Kim
Hyoseon Yu
Ji Hye Kang
Eun Hee Hong
Min Ho Kang
Mincheol Seong
Heeyoon Cho
Yong Un Shin
author_facet Ji Hong Kim
Hyoseon Yu
Ji Hye Kang
Eun Hee Hong
Min Ho Kang
Mincheol Seong
Heeyoon Cho
Yong Un Shin
author_sort Ji Hong Kim
collection DOAJ
description Purpose. This study aimed to evaluate the expression of microRNAs (miRNAs) and inflammasomes in diabetes-induced retinal cells and to determine their role in the pathogenesis of diabetic retinopathy (DR). Methods. To establish diabetes-induced cell models, ARPE-19 cells were treated with high glucose. The expression levels of five miRNAs (miR-185, miR-17, miR-20a, miR-15a, and miR-15b) were measured in high glucose-treated ARPE-19 cells using real-time quantitative polymerase chain reaction. Western blotting was performed to measure inflammasome expression in cellular models. miR-17 was selected as the target miRNA, and inflammasome expression was measured following the transfection of an miR-17 mimic into high glucose-treated ARPE-19 cells. Results. In high glucose-treated ARPE-19 cells, miRNA expression was substantially downregulated, whereas that of inflammasome components was significantly increased. Following the transfection of the miR-17 mimic into high glucose-treated ARPE-19 cells, the levels of inflammasome components were significantly decreased. Conclusions. This study investigated the relationship between miRNAs and inflammasomes in diabetes-induced cells using high glucose-treated ARPE-19 cells. These findings suggested that miR-17 suppresses inflammasomes, thereby reducing the subsequent inflammatory response and indicating that miRNAs and inflammasomes could serve as new therapeutic targets for DR.
format Article
id doaj-art-1843d005e11946f28334b634318c34e3
institution Kabale University
issn 2090-0058
language English
publishDate 2024-01-01
publisher Wiley
record_format Article
series Journal of Ophthalmology
spelling doaj-art-1843d005e11946f28334b634318c34e32025-01-03T01:41:34ZengWileyJournal of Ophthalmology2090-00582024-01-01202410.1155/2024/3654690MicroRNA Regulation for Inflammasomes in High Glucose-Treated ARPE-19 CellsJi Hong Kim0Hyoseon Yu1Ji Hye Kang2Eun Hee Hong3Min Ho Kang4Mincheol Seong5Heeyoon Cho6Yong Un Shin7Department of OphthalmologyDepartment of OphthalmologyDepartment of OphthalmologyDepartment of OphthalmologyDepartment of OphthalmologyDepartment of OphthalmologyDepartment of OphthalmologyDepartment of OphthalmologyPurpose. This study aimed to evaluate the expression of microRNAs (miRNAs) and inflammasomes in diabetes-induced retinal cells and to determine their role in the pathogenesis of diabetic retinopathy (DR). Methods. To establish diabetes-induced cell models, ARPE-19 cells were treated with high glucose. The expression levels of five miRNAs (miR-185, miR-17, miR-20a, miR-15a, and miR-15b) were measured in high glucose-treated ARPE-19 cells using real-time quantitative polymerase chain reaction. Western blotting was performed to measure inflammasome expression in cellular models. miR-17 was selected as the target miRNA, and inflammasome expression was measured following the transfection of an miR-17 mimic into high glucose-treated ARPE-19 cells. Results. In high glucose-treated ARPE-19 cells, miRNA expression was substantially downregulated, whereas that of inflammasome components was significantly increased. Following the transfection of the miR-17 mimic into high glucose-treated ARPE-19 cells, the levels of inflammasome components were significantly decreased. Conclusions. This study investigated the relationship between miRNAs and inflammasomes in diabetes-induced cells using high glucose-treated ARPE-19 cells. These findings suggested that miR-17 suppresses inflammasomes, thereby reducing the subsequent inflammatory response and indicating that miRNAs and inflammasomes could serve as new therapeutic targets for DR.http://dx.doi.org/10.1155/2024/3654690
spellingShingle Ji Hong Kim
Hyoseon Yu
Ji Hye Kang
Eun Hee Hong
Min Ho Kang
Mincheol Seong
Heeyoon Cho
Yong Un Shin
MicroRNA Regulation for Inflammasomes in High Glucose-Treated ARPE-19 Cells
Journal of Ophthalmology
title MicroRNA Regulation for Inflammasomes in High Glucose-Treated ARPE-19 Cells
title_full MicroRNA Regulation for Inflammasomes in High Glucose-Treated ARPE-19 Cells
title_fullStr MicroRNA Regulation for Inflammasomes in High Glucose-Treated ARPE-19 Cells
title_full_unstemmed MicroRNA Regulation for Inflammasomes in High Glucose-Treated ARPE-19 Cells
title_short MicroRNA Regulation for Inflammasomes in High Glucose-Treated ARPE-19 Cells
title_sort microrna regulation for inflammasomes in high glucose treated arpe 19 cells
url http://dx.doi.org/10.1155/2024/3654690
work_keys_str_mv AT jihongkim micrornaregulationforinflammasomesinhighglucosetreatedarpe19cells
AT hyoseonyu micrornaregulationforinflammasomesinhighglucosetreatedarpe19cells
AT jihyekang micrornaregulationforinflammasomesinhighglucosetreatedarpe19cells
AT eunheehong micrornaregulationforinflammasomesinhighglucosetreatedarpe19cells
AT minhokang micrornaregulationforinflammasomesinhighglucosetreatedarpe19cells
AT mincheolseong micrornaregulationforinflammasomesinhighglucosetreatedarpe19cells
AT heeyooncho micrornaregulationforinflammasomesinhighglucosetreatedarpe19cells
AT yongunshin micrornaregulationforinflammasomesinhighglucosetreatedarpe19cells